Menu

CyberKnife Treatment for Prostate Cancer

Author: Ian C. Langtree - Writer/Editor for Disabled World (DW)
Published: 3 Sep 2010 - Updated: 2 Aug 2024
Publication Type: Informative

Contents: Synopsis - Introduction - Main - Related Publications

Synopsis: CyberKnife radiosurgery treatment for prostate cancer is fast effective has no side effects and is non-invasive.

Introduction

CyberKnife radiosurgery treatment for prostate cancer is rapid, effective and has no side effects, with the added benefit of being non-invasive.

Main Content

Prostate Cancer is diagnosed in more than a quarter of a million men each year in the U.S. Treatment options in existence which are non-invasive with little to no side effects are practically none. CyberKnife treatment for prostate cancer literally kills the cancer cells with a precisely targeted beam of radiation that does not affect surrounding tissue or organs.

CyberKnife Treatment requires:

Incorporating a compact, lightweight linear accelerator mounted on a robotic arm, the CyberKnife provides unparalleled flexibility in targeting tumors and lesions. Advanced image guidance technology tracks patient and target position during treatment, ensuring sub millimeter accuracy.

The CyberKnife with its Dynamic Tracking Software is cleared by the FDA to provide radio-surgery for lesions anywhere in the body when radiation treatment is indicated. The CyberKnife has often been used to radio-surgically treat otherwise un-treatable tumors or inoperable tumors. The system treats tumors at body sites unreachable by other stereotactic systems.


Ian C. Langtree Author Credentials: Ian is the founder and Editor-in-Chief of Disabled World, a leading resource for news and information on disability issues. With a global perspective shaped by years of travel and lived experience, Ian is a committed proponent of the Social Model of Disability-a transformative framework developed by disabled activists in the 1970s that emphasizes dismantling societal barriers rather than focusing solely on individual impairments. His work reflects a deep commitment to disability rights, accessibility, and social inclusion. To learn more about Ian's background, expertise, and accomplishments, visit his .

Dropping the Cancer Label May Cut Prostate Deaths

A UCLA-led model finds relabeling the lowest-risk prostate cancer could cut overtreatment and prevent nearly 2,400 deaths a year through more screening. Published: 1 Jul 2026.

Two-Week Radiotherapy Matches Eight-Week Prostate Cancer Treatment

A decade-long phase 3 trial shows 2 week radiotherapy is as safe and effective as 8 week treatment for prostate cancer, with similar survival and side effects. Published: 5 May 2025.

PI-RADS: Prostate Imaging Reporting and Data System Chart

This article outlines the Prostate Imaging Reporting and Data System (PI-RADS), a critical tool for evaluating prostate cancer risk. Published: 27 Jan 2025.

Understanding Gleason Scores in Prostate Cancer Diagnosis

A clear guide to the Gleason scoring system, explaining how pathologists grade prostate cancer from 6 to 10 and what each score means for treatment choices. Published: 26 Jan 2025.

Omega-3 Diet May Slow Prostate Cancer Cell Growth

UCLA study shows men with early-stage prostate cancer who followed a low omega-6, high omega-3 diet with fish oil had 15% less cancer cell proliferation. Published: 14 Dec 2024.

New Report Highlights Long-Term Risks Associated With Prostate Cancer Treatment

PSA screening decisions require clear data on treatment risks and benefits, but current guides lack specific risk estimates. Published: 7 Nov 2024.

View the Full List of Related Publications

What People Are Saying

Start, or join, thought-provoking conversations with other Disabled World readers on this topic.

Share This Information

Permalink:

<a href="https://www.disabled-world.com/health/cancer/prostate/cyberknife-treatment.php">CyberKnife Treatment for Prostate Cancer</a>: CyberKnife radiosurgery treatment for prostate cancer is fast effective has no side effects and is non-invasive.

While we strive to provide accurate, up-to-date information, our content is for general informational purposes only. Please consult qualified professionals for advice specific to your situation.